Cardinal Health Raises 2026 Profit Forecast Amid Strong Specialty Drug Demand
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 30 2026
0mins
Source: Newsfilter
- Profit Forecast Increase: Cardinal Health raised its 2026 adjusted profit forecast to between $10.7 and $10.8 per share, significantly up from the previous range of $10.15 to $10.35, reflecting strong confidence in the robust demand for high-priced specialty and branded drugs.
- Quarterly Earnings Beat: The company reported an adjusted profit of $3.17 per share for the third quarter, surpassing analyst expectations of $2.79 per share, indicating strong performance in the high-margin pharmaceuticals sector.
- Sales Miss Expectations: Despite reporting total sales of $60.9 billion for the third quarter, this figure fell short of the $61.7 billion analysts had anticipated, suggesting challenges in overall sales despite high demand.
- Specialty Drug Market Expansion: Cardinal Health is actively expanding its presence in the specialty drug market through acquisitions of physician practices and specialty care networks, aiming to diversify beyond traditional drug distribution in response to market dynamics.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CAH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CAH
Wall Street analysts forecast CAH stock price to rise
11 Analyst Rating
10 Buy
1 Hold
0 Sell
Strong Buy
Current: 199.850
Low
209.00
Averages
225.18
High
244.00
Current: 199.850
Low
209.00
Averages
225.18
High
244.00
About CAH
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Diversification Strategy: Jim Cramer emphasized the need for diversification even as artificial intelligence dominates the market, ensuring long-term stability in investment portfolios to mitigate risks associated with single-theme investments.
- Stock Recommendations: Cramer recommended four stocks for new members to buy, including Alphabet, Amazon, Apple, and Nvidia, all of which demonstrate strong growth potential, particularly in their AI-related businesses.
- Market Outlook: Despite challenges faced by Meta and Microsoft, Cramer remains cautiously optimistic about their future performance, suggesting that these companies could achieve breakthroughs in the evolving AI landscape.
- Emerging Investment Opportunities: Stocks like Arm Holdings and Broadcom are showing strong performance, particularly in the data center and AI chip sectors, reflecting robust market demand for related technologies, making them worth watching for long-term growth potential.
See More
- Bond Yields Surge: On Tuesday, the 30-year Treasury yield reached its highest level in nearly 19 years, with Jim Cramer warning that rising rates typically signal inflationary pressures, suggesting investors should consider selling stocks to mitigate risks.
- Strong Home Depot Performance: Home Depot reported earnings that exceeded expectations before the bell and reaffirmed its full-year guidance, demonstrating resilience amid economic uncertainty, which may attract more investor interest.
- Cardinal Health Stock Recovery: Cardinal Health's stock rose about 1.5% to $203, with Jim Cramer believing the company has the potential to rebound to $220, endorsing its growth strategy of acquiring physician practice operations and suggesting it’s a good time for investors to buy.
- Blackstone and Google Partnership: Blackstone announced a $5 billion investment in a new AI infrastructure company that will utilize Google TPUs developed in collaboration with Broadcom, with Jim Cramer highlighting Broadcom's crucial role in this partnership, despite its shares declining nearly 2%.
See More
- Yield Comparison: Johnson & Johnson (JNJ) offers a 2.26% yield with a $1.34 quarterly dividend, marking its 64th consecutive annual increase, which underscores its robust cash flow and shareholder return capability, thereby boosting investor confidence.
- Financial Services Performance: Morgan Stanley (MS) provides a 2.1% yield backed by a 27.1% ROTCE for Q1 2026 and $1.75 billion in buybacks, indicating strong performance in capital management and shareholder returns.
- Risk vs. Reward: The Iran war has heightened inflation expectations, forcing investors to choose between 3% municipal bonds and 13% business development companies, reflecting market sensitivity to risk and the pursuit of yield, which impacts investment strategies.
- Yield Structure: The current yield spectrum ranges from 3% to 13%, requiring investors to weigh safety against high-risk returns, especially amid ongoing Middle East conflicts, as the demand for yield remains strong in the market.
See More
- Rising Bond Yields: The massive bond selloff pushed the 10-year Treasury yield to approximately 4.6% and the 30-year yield above 5.1%, which could lead to increased borrowing costs, thereby affecting corporate investment decisions and consumer spending.
- Oil Price Surge: West Texas Intermediate crude oil prices climbed back above $105 per barrel, and this rise in oil prices may exacerbate inflation concerns, potentially impacting consumer confidence and spending, especially in a high-inflation environment.
- Volatility in AI Stocks: Stocks like Arm Holdings and Nvidia experienced profit-taking as enthusiasm for AI waned, indicating a cautious investor sentiment towards high-risk assets amid rising interest rates and oil prices.
- Upcoming Earnings Reports: A significant week of earnings is ahead with key companies like Home Depot and Nvidia scheduled to report, and the market will closely monitor these results for their potential impact on stock prices in the context of increasing economic uncertainty.
See More
- Boeing Order Reaction: Despite China agreeing to order 200 Boeing jets, the market reacted negatively, causing Boeing shares to drop about 4% and erase all gains since the CEO's trip to China, reflecting investor disappointment over the order size.
- Market Performance Review: The Dow Jones Industrial Average has surpassed 50,000 points again, led by technology stocks, with financials, staples, and industrials also participating, indicating a broad market rally and increased investor confidence in economic recovery.
- Dover Investment Expansion: Dover announced a $30 million investment in its subsidiary SWEP to expand manufacturing capacity for brazed plate heat exchangers crucial for AI data center cooling, which is expected to more than double capacity to meet rising market demand.
- Pharmaceutical Industry Dynamics: IQVIA reported a 1.4% year-over-year increase in prescription drug volumes for April, providing hope for pharmaceutical distributors like Cardinal Health, potentially helping its stock find support after a 20% pullback.
See More
- Memory Supercycle: The Roundhill Memory ETF (DRAM) attracted over $5 billion in investments within a month, including $1.1 billion on Thursday alone, indicating strong market demand for memory stocks driven by surging AI computing needs.
- Core Holdings Performance: The ETF's core holdings feature leading memory manufacturers like SK Hynix, Micron, and Samsung, allowing investors to gain broad exposure to these high-growth companies, including those not listed on U.S. exchanges.
- Market Reaction: Micron's stock surged over 200 points in a week, climbing from $542 to $747, reflecting optimistic market expectations for memory product demand, with a price-to-earnings ratio of only 9 times projected earnings for the next 12 months, highlighting its appeal as a quality stock.
- Investment Opportunities: Despite waning interest in data center stocks, investors can still capitalize on potential gains in the memory and cooling sectors by purchasing instruments like the DRAM ETF, especially as major tech companies continue to invest heavily in data centers.
See More











